Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23,420 | 6 | 98.9% |
| Food and Beverage | $253.71 | 9 | 1.1% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ethicon Inc. | $18,420 | 4 | $0 (2020) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $2,500 | 1 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $2,500 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $159.31 | 7 | $0 (2024) |
| Sight Sciences, Inc. | $82.45 | 1 | $0 (2023) |
| Carl Zeiss Meditec, Inc. | $11.95 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $159.31 | 7 | Janssen Pharmaceuticals, Inc ($159.31) |
| 2023 | $82.45 | 1 | Sight Sciences, Inc. ($82.45) |
| 2020 | $823.28 | 1 | Ethicon Inc. ($823.28) |
| 2019 | $20,109 | 6 | Ethicon Inc. ($17,597) |
| 2018 | $0 | 1 | Auris Health, Inc. |
| 2017 | $2,500 | 1 | Valeant Pharmaceuticals North America LLC ($2,500) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Neuroscience | ||||||
| 11/27/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $34.72 | General |
| Category: Neuroscience | ||||||
| 10/02/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Neuroscience | ||||||
| 07/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Neuroscience | ||||||
| 07/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Neuroscience | ||||||
| 06/21/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Neuroscience | ||||||
| 05/23/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Neuroscience | ||||||
| 02/16/2023 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $82.45 | General |
| Category: Ophthalmology | ||||||
| 07/08/2020 | Ethicon Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $823.28 | General |
| 08/13/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX (Drug), VYZULTA, PROLENSA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/15/2019 | Ethicon Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $64.29 | General |
| 07/15/2019 | Ethicon Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $0.32 | General |
| 06/28/2019 | Carl Zeiss Meditec, Inc. | — | Food and Beverage | In-kind items and services | $11.95 | General |
| 05/09/2019 | Ethicon Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $17,532.52 | General |
| 2019 | Auris Health, Inc. | — | — | — | $0.00 | Ownership |
| 2018 | Auris Health, Inc. | — | — | — | $0.00 | Ownership |
| 10/26/2017 | Valeant Pharmaceuticals North America LLC | PROLENSA (Drug), LOTEMAX GEL, VICTUS | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 6 | 191 | 240 | $229,853 | $26,195 |
| 2020 | 5 | 117 | 148 | $151,425 | $16,412 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of lens, simple | Facility | 2021 | 27 | 34 | $128,180 | $17,153 | 13.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 55 | 57 | $39,900 | $3,438 | 8.6% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 37 | 51 | $25,245 | $2,260 | 9.0% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 28 | 28 | $23,324 | $1,592 | 6.8% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2021 | 29 | 54 | $8,964 | $1,373 | 15.3% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 15 | 16 | $4,240 | $378.72 | 8.9% |
| 66984 | Removal of cataract with insertion of lens | Facility | 2020 | 17 | 22 | $82,940 | $10,711 | 12.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Facility | 2020 | 35 | 35 | $24,500 | $1,814 | 7.4% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Facility | 2020 | 26 | 40 | $19,644 | $1,520 | 7.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 14 | 14 | $9,800 | $1,034 | 10.6% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Facility | 2020 | 13 | 13 | $10,829 | $911.11 | 8.4% |
| 92136 | Measurement of corneal curvature and depth of eye | Facility | 2020 | 12 | 24 | $3,712 | $421.71 | 11.4% |
About Dr. Stephen Mcleod, MD
Dr. Stephen Mcleod, MD is a Ophthalmology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093767592.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Mcleod, MD has received a total of $23,674 in payments from pharmaceutical and medical device companies, with $159.31 received in 2024. These payments were reported across 17 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($23,420).
As a Medicare-enrolled provider, Mcleod has provided services to 308 Medicare beneficiaries, totaling 388 services with total Medicare billing of $42,607. Data is available for 2 years (2020–2021), covering 12 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location San Francisco, CA
- Active Since 05/16/2006
- Last Updated 06/12/2008
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1093767592
Products in Payments
- LOTEMAX (Drug) $2,500
- PROLENSA (Drug) $2,500
- INVEGA SUSTENNA (Drug) $159.31
- OMNI SURGICAL SYSTEM (Device) $82.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in San Francisco
Dr. Daniel Schwartz, M.d, M.D
Ophthalmology — Payments: $8.0M
Shan Lin, Md, MD
Ophthalmology — Payments: $437,860
Dr. Eugene De Juan, Md, MD
Ophthalmology — Payments: $349,911
Dr. H Tanaka, Md, MD
Ophthalmology — Payments: $326,711
Dr. Jay Stewart, Md, MD
Ophthalmology — Payments: $295,001
Dr. Scott So, M.d, M.D
Ophthalmology — Payments: $172,800